AblationforCardiacArrhythmias near Newark, NJ

Biography: Dr. Ellie Coromilas, MD is a Cardiology Specialist who practices in New York, NY. She is 38 years old. Dr. Ellie Coromilas, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center and New York-Presbyterian Hospital/Lawrence.

Biography: Dr. Emily J. Tsai is the Florence Irving Associate Professor of Medicine at Columbia University Vagelos Colleges of Physicians and Surgeons and an attending physician at the Center for Advanced Cardiac Care of New York-Presbyterian Hospital at Columbia University Irving Medical Center. Board-certified in Cardiovascular Medicine and Advanced Heart Failure and Transplant Cardiology, Dr. Tsai specializes in caring for heart failure patients who require, or who have received, a ventricular assist device or heart transplant. Dr. Tsai is a magna cum laude graduate in engineering sciences of Harvard College and a cum laude graduate of Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology Program. She completed internal medicine residency training at the Hospital of the University of Pennsylvania and then cardiology fellowship and advanced heart failure and transplant cardiology training at The Johns Hopkins Hospital. As a Ruth L. Kirschstein National Research Service Awardee, Dr. Tsai completed post-doctoral basic cardiovascular research training at Johns Hopkins University in the laboratory of Dr. David A. Kass. After fellowship training, Dr. Tsai was recruited to Temple University School of Medicine as an assistant professor of medicine and physiology and a principal investigator in its Cardiovascular Research Center. In 2015, Dr. Tsai joined the faculty of Columbia University College of Physicians & Surgeons and established her laboratory in molecular and integrative cardiac pathophysiology.As a physician-scientist, Dr. Tsai studies the molecular and cellular biology of heart failure with the goal of developing novel therapies. Major areas of research in Dr. Tsai's laboratory include the signaling of soluble guanylyl cyclase (the nitric oxide receptor) in the heart, right heart dysfunction, and cardiac complications associated with COVID-19. Dr. Tsai has been nationally recognized for her scientific achievements by the American College of Cardiology and the Heart Failure Society of America, with their respective Presidential Career Development Award and Jay N. Cohn New Investigator in Basic Sciences Award. She has been awarded several research grants from the National Institutes of Health, American Heart Association, Foundation of Gender Specific Medicine, and the Columbia University Provost's Grants Program. Dr. Tsai has served on national committees of the American College of Cardiology, American Heart Association, and Heart Failure Society of America.

Biography: Dr. Karan Wats is an Assistant Professor of Medicine and Cardiologist, specializing in the diagnosis and treatment of patients with advanced heart failure. His practice includes those requiring left ventricular assist device or heart transplantation. He also attends as a cardiac intensivist. He is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography, Nuclear Cardiology, Hypertension and Advanced Heart Failure & Transplant Cardiology. Dr. Wats received his medical degree from Dayanand Medical College and Hospital, India. He completed his internship and residency in Internal Medicine at Maimonides Medical Center. He then went on to do Hypertension Research fellowship at Icahn School of Medicine at Mount Sinai followed by Cardiology fellowship at Maimonides Medical Center and Advanced Heart Failure, Transplant fellowship at Westchester Medical Center. He is particularly interested in infiltrative cardiomyopathy and currently serves as an associate director for amyloid program.

Biography: Dr. Edward Lin, MD is an Advanced Heart Failure /amp Transplant Cardiology Specialist who practices in New York, NY. He is 41 years old and has been practicing for 26 years. Dr. Edward Lin, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Poterucha is an Assistant Professor of Medicine in the Division of Cardiology at Columbia University Irving Medical Center who specializes in clinical research, cardiac imaging, and clinical cardiology. He received his MD from Mayo Clinic School of Medicine and completed a residency in internal medicine at Brigham and Women's Hospital after which he served on the faculty at Brigham and Women's Hospital and Harvard Medical School. He subsequently pursued fellowships in cardiology and advanced echocardiography at Columbia University Irving Medical Center.Dr. Poterucha's research focuses on using novel tools, including artificial intelligence analysis of cardiovascular testing, to improve the care of patients with cardiovascular disease. This includes the development of diagnostic algorithms using large-scale retrospective database analysis of ECGs and echocardiograms and the prospective validation of those tools. His aim is to ensure that these tools are deployed equitably to improve care in patients experiencing fractured or inadequate medical care.Clinically, Dr. Poterucha's areas of expertise include transthoracic echocardiography, transesophageal echocardiography, and cardiac stress testing. He serves as a clinical cardiologist on patients admitted to NewYork-Presbyterian Columbia University Irving Medical Center. He is an enthusiastic medical educator and is involved in teaching medical students, residents, and fellows.

Biography: Dr. Michael Fremed, MD is a Pediatric Cardiology Specialist who practices in New York, NY. He has been practicing for 10 years. Dr. Michael Fremed, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Ellis Rochelson, MD is a Pediatric Cardiology Specialist who practices in New York, NY. He is 38 years old and has been practicing for 11 years. Dr. Ellis Rochelson, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: I began my academic career following cardiology fellowship as junior faculty at Columbia University Medical Center where I helped start the Nuclear Cardiology laboratory which was one of the first laboratories to perform perfusion imaging and gated blood pool scintigraphy in NYC. I remained at CU for 18 years doing clinical research, involved in phase II and phase III trials of perfusion imaging agents such as sestamibi as well as early radiolabeled antibody clinical trials targeting myocardial necrosis in patients with acute MI. I also helped develop radiotracers using relevant animal models of ischemic heart disease, atherosclerosis, and cardiac transplantation. I left CU to go to University of Alabama at Birmingham as Director of Nuclear Cardiology and stayed for 2 years where I also did some work with the cardiac MRI program. From UAB I moved to Brown University/Rhode Island Hospital as Director of Nuclear Cardiology where I stayed for 10 years having the opportunity to also direct their preclinical imaging laboratory. In 2005 I returned to a faculty position at CU. I have had a long interest to develop and apply novel imaging probes targeting sites in vasculature and myocardium that are important in clinical disease. I have performed preclinical experimental studies imaging myocardial tissue hypoxia, apoptosis, angiogenesis and RAGE expression. I have had a particular interest in imaging the vulnerable atherosclerotic plaque using radionuclide labeled probes in mouse and pig models of atherosclerosis, investigating uptake of tracers targeting apoptosis, metalloproteinase activation, expression of Receptor for Advanced Glycated Endproducts (RAGE), and selective VEGF receptor expression. With institutional support from the Department of Medicine and Division of Cardiology I set up a preclinical molecular imaging core laboratory that offers micro-CT, micro-SPECT/CT, and optical imaging resources for investigators with animals outside the barrier at Columbia University Health Sciences. I have had continuous NIH funding for about 20 years. I am currently PI (or co-PI) on two R01s: to using imaging to detect therapeutic effect of a novel antibody blocking RAGE to improve hind limb blood flow in a diabetic pig model of PAD, and in collaboration with the laboratory of Dr. Jeanine D'Armiento, to perform a phase II clinical trial of 99mTc rhAnnexin-128 (Advanced Accelerator Applications, France) to image lung apoptosis in patients with COPD under an individual IND (L Johnson). I have published over 100 papers.

Biography: Siqin Ye, MD, MS, FACC is a general cardiologist and the Director of Cardiology Inpatient Consultation Service, the Heart Institute Inpatient Service, and the Ambulatory Cardiology Fellowship Program. He has previously served as the Associate Chief Medical Officer for ColumbiaDoctors, the faculty practice of Columbia University Irving Medical Center (CUIMC), in which role he directed key population health and telemedicine programs, including the conversion of all outpatient practices to telemedicine during the Covid-19 pandemic. He has conducted NIH-funded research examining informatics approaches to improve shared decision-making for statin therapy, as well as outcomes research on the implementation and evaluation of telemedicine for ambulatory care. His clinical practice is focused on providing hospital based cardiac care at CUIMC.

Biography: Steven O. Marx, M.D., is the Director of the Cardiovascular Fellowship Program at Columbia University Medical Center/NewYork-Presbyterian Hospital and is director of the cardiology component of a NIH training grant for cardiology fellows and surgery residents. His research program in cardiovascular diseases at Columbia has been focused in two major areas: molecular cardiology, particularly the regulation of ion channels in normal and pathological conditions in the heart, and vascular biology, particularly the molecular mechanisms of vascular smooth muscle proliferation, migration and contractility. Working with others at Columbia, Dr. Marx has identified rapamycin (sirolimus) as a therapeutic agent for preventing restenosis after angioplasty/stent implantation. He also characterized the dysfunction of the ryanodine receptor in heart failure. A major focus of Dr. Marx's current research is the regulation of arterial contractility and blood pressure by the ion channels. Dr. Marx received his B.S. in Biology from Union College and M.D. from Albany Medical College as part of a six-year program. Following a one-year postdoctoral fellowship in ion channel research at Johns Hopkins, he completed an internship and residency at the University of Rochester-Strong Memorial Hospital followed by a Cardiology Fellowship and a Clinical Electrophysiology Fellowship at Mount Sinai Medical Center. He is board certified in Internal Medicine, Cardiology and Clinical Cardiac Electrophysiology. He is also the principal investigator of several NIH R01 grants and a T32 grant. Dr. Marx has served on NIH and AHA peer review committees, is a member of the AHA Founders Affiliate Research Committee, and serves on the New York Academy of Medicine Glorney-Raisbeck Selection Committee.

Biography: Dr. Shimbo received a B.S. from the Johns Hopkins University in Biomedical Engineering and a M.D. from Albany Medical College. He then completed a residency in Internal Medicine at Mount Sinai Hospital, and was selected as Chief Resident. He subsequently completed a fellowship in Cardiovascular Medicine, also at the Mount Sinai Hospital, before joining the faculty at Columbia University in September 2003. Currently, Dr. Shimbo is a board-certified cardiologist and Professor of Medicine in the Division of Cardiology in the Department of Medicine at Columbia University Irving Medical Center. He co-directs the Columbia Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension. Dr. Shimbo's clinical interests include the accurate diagnosis and treatment of hypertension, and evaluating the cardiovascular manifestations of hypertension. Dr. Shimbo conducts rigorous, innovative, interdisciplinary research that increases the understanding of the behavioral, psychosocial and biological processes in the pathogenesis of the increased cardiovascular disease risk associated with hypertension.

Biography: Dr. Shames has completed her training in Cardiology at McGill University, Montreal, Canada followed by a research fellowship under the supervision of Dr. Linda Gillam at CUMC. She is board certified in Adult Cardiology and Adult Echocardiography. Her main area of expertise and research interest is adult echocardiography including transthoracic, transesophageal, and stress echocardiography. She is actively engaged in teaching cardiology fellows rotating through the echo lab.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Sooraj Shah, MD is a Cardiology Specialist who practices in New York, NY. He is 43 years old and has been practicing for 20 years. Dr. Sooraj Shah, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Stacy W. Baird, MD is an Assistant Professor of Medicine at Columbia University Medical Center. She is a cardiologist with expertise in non-invasive imaging, focusing on stress testing, transesophageal echocardiography and 2D-echocardiography in the diagnosis and evaluation of cardiac conditions. Dr. Baird received her undergraduate degree from Princeton University and her medical degree from Johns Hopkins University School of Medicine. She completed her internship and medical residency at The Johns Hopkins Hospital, followed by fellowship training in Cardiovascular Diseases at New York-Presbyterian Hospital/Columbia University Medical Center. Following fellowship, Dr. Baird then completed an Advanced Fellowship in Echocardiography at NewYork-Presbyterian/Columbia, with a focus on the use of 3D-echocardiography and transesophageal echocardiography in the evaluation of cardiovascular diseases, particularly valvular heart disease. She is board certified in cardiology, echocardiography, and nuclear cardiology.

Biography: Reema Bhatt, MD, is an attending cardiologist at NewYork-Presbyterian Queens and an assistant professor of clinical medicine at Weill Cornell Medicine. Dr. Bhatt is board certified and specializes in cardiovascular disease, advanced heart failure, transplant cardiology, and echocardiography.Dr. Bhatt is a member of the American College of Cardiology, the Heart Failure Society of America, and The International Society for Heart and Lung Transplantation. She has given lectures and case presentations, and has published peer-review articles and abstracts.After graduating from Drexel University College of Medicine, Dr. Bhatt completed her residency training in internal medicine at Temple University Hospital. She served her fellowship in cardiovascular disease at Rush University Medical Center and was named chief cardiology fellow during her final year. Dr. Bhatt completed her fellowship in advanced heart failure and transplant cardiology at Weill Cornell Medical Center.She is fluent in English and Gujarati.

Biography: Ningxin Wan, MD, is a cardiologist at NewYork-Presbyterian Medical Group Queens and an assistant professor of clinical medicine at Weill Cornell Medicine. She sees patients at NewYork-Presbyterian Queens and Weill Cornell Medical Center. Dr. Wan is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation and has published research in medical journals, including the Journal of Nuclear Cardiology. After graduating from Peking Union Medical College in Beijing, China, Dr. Wan served her residency in internal medicine at Jacobi Medical Center in the Bronx, New York. She completed a three-year fellowship in cardiovascular disease at Montefiore Medical Center and remained there to continue her fellowship training, focusing on advanced heart failure and transplant cardiology, during her final year.

Biography: Nathan Tehrani, MD, is a cardiologist at NewYork-Presbyterian Medical Group Queens who is board certified in cardiovascular disease, echocardiography, nuclear cardiology, vascular ultrasound interpretation, and internal medicine. Dr. Tehrani earned his medical degree from the American University of the Caribbean and completed his internal medicine residency at NewYork-Presbyterian Brooklyn Methodist Hospital. After residency, he pursued a cardiac imaging research fellowship at Weill Cornell Medical College where he performed NIH and foundation sponsored research focusing on multimodality aortic imaging and ischemic mitral regurgitation. Dr. Tehrani served his cardiology fellowship at NewYork-Presbyterian Queens, where he was named chief cardiology fellow during his final year. Dr. Tehrani's research has been presented at the American College of Cardiology scientific sessions and published in medical journals including the Journal of the American Heart Association.